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At any given time, approximately 27% of patients in the
United States (US) receive hemodialysis through a permanent
catheter. However, this cross-sectional estimate may
significantly underestimate the lifetime exposure of patients
to hemodialysis catheters, and hence, to the excess risk of the
adverse clinical events associated with catheter use. To
further clarify catheter use in hemodialysis patients, we
identified a cohort of fistula and graft patients in the US
Renal Data System using Current Procedural Terminology
(CPT) codes. Patients were included if their first hemodialysis
was between 1 January 1996 and 31 December 2001, and
Medicare was their primary payer. We identified permanent
catheter insertions in these patients using CPT codes starting
6 months before their first hemodialysis session (or fistula or
graft placement, if earlier), and ending 40 months afterward.
Most patients (82%) were 465 years old, 57% were male,
and 72% were white. The overall rate of permanent catheter
insertions was 44 per 100 patient years, with 57% of patients
having at least one catheter insertion. The percent of patients
receiving a catheter was similar before (30%) and after (27%)
the first fistula or graft placement. Cross-sectional analysis
may significantly underestimate the lifetime risk of exposure
to hemodialysis catheters. Because catheter use is common
even in fistula and graft patients, measures used to prevent
adverse events associated with catheter use are important in
all patients regardless of current access type.
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BACKGROUND
Because of the morbidity and mortality associated with the
use of catheters in hemodialysis patients, the National Kidney
Foundation has established guidelines, recommending that
no more than 10% of hemodialysis patients use permanent
catheters as their primary access method.1 One reason for the
recommendation is that local and systemic infections occur
more frequently with catheters than with an autologous
fistula or synthetic graft.2–5 Specifically, the Centers for
Disease Control and Prevention have reported United States
(US) bacteremia rates per 100 patient-months of 0.2 for
fistulas, 0.5 for grafts, 5.0 for cuffed catheters, and 8.5 for
non-cuffed catheters.6 Similarly, adjusted relative rates of
septicemia in the US were reported to be 48% higher for
temporary catheters and 34% higher for grafts when
compared to fistulas.7 These relative rates were even higher
during the initial 6 months of hemodialysis.
Other evidence underlying the recommendation to reduce
catheter use is that cuffed catheters are associated with lower
blood flow rates compared to arteriovenous grafts and
fistulas, which can compromise dialysis adequacy.8 Catheters
may also be associated with central venous stenosis, which
can preclude later placement of permanent access.9,10 Finally,
there is evidence of a relationship between mortality and the
type of vascular access, with both grafts and catheters
associated with higher mortality than fistulas after adjust-
ment for potential confounding variables.11,12
Although it is clear that there are important clinical
complications associated with catheter use, enumerating the
population at risk is more complicated. According to the
2003 end-stage renal disease Clinical Performance Measures
Project (CPMP) report, 27% of patients in the US used
catheters as their primary access type at a single point in
time, and 21% did so for 90 days or more.13 On the surface
this suggests that, while the US is not yet close to achieving
the 10% National Kidney Foundation goal, the majority of
hemodialysis patients in the US are not at high risk for
complications associated with catheters.
However, this view is misleading because the data also
show that the catheter population is made up, in significant
part, by fistula or graft patients: 27% of catheter patients use
catheters while their fistula or graft matures, 14% use
catheters owing to clotting or revision of their current fistula
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or graft, and 12% use catheters after having exhausted all
fistula and graft sites.13 (For the remainder, 40% had no
existing or planned graft or fistula and 6% reported ‘other’
reasons for using catheters.)
Therefore, while the data taken at a single point in time
might suggest that the majority of the hemodialysis
population – the entire fistula and graft population – is not
exposed to catheter-related risks, the reasons for catheter use
indicate otherwise. The goal of this investigation is to
quantify catheter use in fistula and graft patients in order to
understand whether these patients are at increased risk of
catheter-related complications.
RESULTS
Characteristics of the sample
Of the 163 292 patients in the data set during the observation
period, 104 256 (64%) had at least one fistula or graft
placement and were included in the analyses as the study
sample.
Patients with grafts were the largest group, comprising
67% of the sample. There were more men (57%) than women
and the majority of the population was over 70 years of age at
the time of first hemodialysis. On average, there were 8
months of follow-up before the initial fistula or graft
placement and 22 months afterward. See Table 1 for baseline
demographic information.
Permanent catheter insertions in the total study sample
In the total study sample, the unadjusted rate of permanent
catheter insertions was 44 per 100 patient-years of follow-up
with 57% of patients having at least one insertion (either
before or after the initial fistula or graft placement). The
proportion requiring a permanent catheter at any time varied
from 54% for graft patients to 72% for graft/fistula patients
(see Table 2).
Before versus after fistula or graft placement
The unadjusted rate of permanent catheter insertions was
highest in the 6-month period after the initial placement (81
per 100 patient-years overall). The next highest period was
the interval immediately preceding the fistula or graft
placement (61 per 100 patient-years). Later periods had
lower rates of catheter insertion (see Figure 1).
Overall, 30% of patients had at least one permanent
catheter insertion before the initial fistula or graft placement,
and 27% had at least one catheter insertion in the 6-month
period immediately following the initial placement. See
Figure 2 for the cumulative rate of catheter use over time.
Adjusted rate regression analyses
The adjusted analyses provided similar results to the
unadjusted analyses (adjusted rates not shown). The highest
permanent catheter insertion rates were in the 6-month
period following the initial fistula or graft placement.
Compared to this 6-month period (the reference period),
the rate before the initial placement was 27% lower (relative
rate 0.73, 95% confidence interval (CI) 0.72–0.74) and the
rate in the second 6-month period was 67% lower (relative
rate 0.33, 95% CI 0.32–0.34). The rate after the first 12
months was 75% lower than the first 6-month period
(relative rate 0.25, 95% CI 0.24–0.25).
Fistula use was associated with the lowest rate of
permanent catheter insertions. In comparison to the fistula
group (the reference category), the graft group was associated
with a 3% higher insertion rate for permanent catheters
(relative rate 1.03, 95% CI 1.01–1.50) and the graft/fistula
group was associated with a 65% higher rate (relative rate
1.65, 95% CI 1.61–1.70).
The reference group for vintage was patients whose initial
fistula or graft placement occurred in the 4-month interval
after starting hemodialysis. Patients whose placement
occurred before starting hemodialysis had a 67% lower rate
of permanent catheter insertions (relative rate 0.33, 95% CI
0.32–0.34). Patients whose placement occurred more than 4
months after starting hemodialysis had a 75% lower rate
(relative rate 0.25, 95% CI 0.24–0.25).
Table 1 | Characteristics of the study population
Variable
Total
population
(N=104 256)
Fistula
(N=22 339)
Graft
(N=70 316)
Graft/fistula
(N=11 601)
Gender (% male) 57 69 53 62
Time of fistula or graft placement (relative to first hemodialysis, %)
Before 31 37 29 30
r4 months
after
50 47 53 37
44 months
after
19 16 18 33
Year of first hemodialysis (%)
1996 16 9 19 13
1997 17 13 18 18
1998 18 15 18 20
1999 17 17 17 21
2000 16 20 15 17
2001 16 26 13 11
Age (years)
o65 22 21 22 26
65–69 18 18 18 19
70+ 60 61 60 55
Mean length of observation period per patient (months)
Before first
placement
8 7 8 7
After first
placement
22 20 22 28
Race (%)
White 72 80 71 70
Black 23 16 25 26
Other 5 4 4 4
ESRD primary cause (%)
Hypertension 27 28 27 27
Diabetes 41 37 42 40
Other 32 35 31 33
ESRD, end-stage renal disease.
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DISCUSSION
Vascular access type has been shown to be associated with
important outcomes including infection and death; accord-
ingly, the National Kidney Foundation guidelines recom-
mend a reduction in catheter use in the hope that outcomes
for patients may be improved. However, the use of catheters
by fistula and graft patients has not been well described,
which makes it difficult to predict the risk of catheter-related
complications in this population.
The present analyses illustrate that access type is dynamic,
and that patients with fistulas and grafts undergo catheter
insertions on a relatively frequent basis. Across a large sample
of patients from 1996 to 2001, 57% had at least one permanent
catheter insertion procedure during the observation period.
Much of the utilization occurred in the period immediately
preceeding, or the 6-month period following, the initial fistula
or graft placement. Although the rate was lower more than 12
months after the initial fistula or graft placement, it was still
measurable. Patients with fistulas had lower rates of catheter
insertion than patients with grafts, and the patients with both
fistula and graft codes had the highest rate. This difference
between grafts and fistulas is consistent with the lower failure
rates seen for fistulas compared to grafts.14
As with any analysis, there are limitations. Coding of
access is very complicated because there are many Current
Procedural Terminology (CPT) codes that can be used,
multiple access types can be in place at a particular time, and
not every insertion and removal may appear in the claims
data due to changes in insurance coverage. We focused our
primary analyses on two main CPT codes for permanent
catheters to avoid as much misclassification as possible.
While some of these codes may have been used for non-
dialysis catheterizations, this is mitigated by the fact that we
excluded other codes that may have been used to indicate
permanent catheters by some physicians. Also, some of these
permanent catheterizations may have actually been better
classified as temporary because of coding irregularities.
However, while the distinction between permanent and
temporary catheters may be somewhat limited given the
coding limitations, the use of permanent catheters as a proxy
for overall catheter exposure is still likely to be conservative.
We tried to reduce the effects of coding errors for grafts
and fistulas by creating a ‘graft/fistula’ group where the access
history was less clear. However, there is likely to be
misclassification of access type despite our best efforts. Also,
because all patients were assumed to have 6 months of
observation before the first hemodialysis visit even if there
were no claims data available, the catheter insertion rates and
proportions are likely to be underestimated, especially in the
period before dialysis initiation.
We also cannot estimate the duration any catheter was in
place using CPT codes. The actual characterization of risks
from catheter use should incorporate this information if it
can be obtained from other sources. The distinction between
‘access in place’ and ‘access in use’ is not possible in this data
set. Hence, placement rates may be somewhat different from
actual usage rates for catheters. Also, these results apply to
patients in whom grafts or fistulas were attempted as
evidenced by the CPT code for fistula or graft. Some patients
Table 2 | Proportions of patients with permanent catheter insertions by timing and access type
Access type
Before initial
placement (%)
r6 Months after
initial placement (%)
6–12 Months after
initial placement (%)
412 Months after
initial placement (%) Any time
Graft 31 24 7 11 54%
Fistula 29 31 5 4 57%
Graft/fistula 27 39 18 27 72%
All subjects 30 27 8 12 57%
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Figure 1 | Rates of permanent catheter insertions by access type.
Unadjusted rates of permanent catheter insertions over time. Time
defined relative to the initial graft or fistula insertion.
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Figure 2 | Cumulative proportion of patients having a catheter
insertion over time. The cumulative proportion of patients having at
least one catheter insertion over time.
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never achieve a mature, functioning fistula or graft for a
variety of reasons, but are nevertheless included in this
analysis and contribute catheter insertions to these results.
Finally, our patient population was older than average
because we focused on patients with Medicare claims in
order to identify catheter use.
In conclusion catheter use is common in hemodialysis
patients who undergo fistula and graft placement. Further-
more, the rate of catheter placement is highest both before
and shortly after the initial fistula or graft placement
procedure, and it declines over time after fistula or graft
placement. As most fistula and graft patients are exposed to
catheter risks at some point in time, measures that can
mitigate catheter-related complications are still very impor-
tant in these patients.
MATERIALS AND METHODS
Design and population
This was a retrospective cohort study using data from the United
States Renal Data System (USRDS) to evaluate the rate of catheter
use in hemodialysis patients with a fistula or graft. All USRDS
patients with a first end-stage renal disease service date between 1
January 1996 and 30 September 2001 were included in the sample.
Patients were included in the data set if their first dialysis modality
was recorded as hemodialysis, and if Medicare was the sole primary
payer at the start of dialysis (to increase the likelihood that access
placement procedures would be captured).
Patients were selected if they had a code indicating either fistula
or graft placement in the observation period. This observation
period began at either 6 months before the first hemodialysis session
or at the first fistula or graft placement, whichever was earlier.
Patients with less than 6 months of claims data before their first
hemodialysis session were assumed to have a complete 6-month
exposure period, but 0 catheter insertions for billing periods with no
data. This assumption was made so that catheter insertion rates
would be estimated conservatively (i.e., low rather than high). The
period ended at death, transplantation, initiation of peritoneal
dialysis, 40 months after first hemodialysis, or the end of the
observation period (31 December 2001). The date of first fistula or
graft placement was defined as the index date for each patient, and
analysis of catheter rates are defined below in reference to this date.
Variable definitions
Patients were categorized using CPT codes according to whether
they had a graft (CPT code 36825 or 36830) or fistula (CPT code
36819, 36820, or 36821) placement procedure.15,16 Patients with
both fistula and graft placement procedures were included in a
separate group, referred to as the graft/fistula group. In order to be
able to differentiate clearly the three groups, patients in the graft
group without a fistula insertion claim but with a fistula revision or
removal claim, as well as the analogous group of fistula patients,
were excluded (o5% of patients).
Permanent catheter insertions were identified using CPT codes
36533 and 36800. Temporary catheter insertions were not included
in the analyses.
Analyses
Unadjusted rates and proportions of patients having at least one
permanent catheter insertion were calculated. Catheter insertion
rates and proportions were calculated for four intervals: before the
initial fistula or graft placement, 0–6 months after the initial
placement, 7–12 months after the initial placement, and 412
months after the initial placement. All rates are expressed as catheter
insertions per 100 patient-years of follow-up.
In addition, a generalized estimating equations (GEE) Poisson
regression model17 of the permanent catheter insertion rate was
developed to evaluate differences between graft, fistula, and graft/
fistula patients across the four intervals identified above, adjusting
for age, race, gender, year starting hemodialysis, time since first
hemodialysis at the time of the initial fistula or graft placement (i.e.,
vintage), and cause of kidney failure. All analyses were performed
using SAS version 9.1 (Cary, NC, USA).
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